Cell And Gene Therapy Manufacturing

  1. Collaborating with the FDA: Dr. Peter Marks and Dr. Nicole Verdun Share Advice For Small And Emerging Biotechs 1/30/2024

    In this segment, Dr. Peter Marks and Dr. Nicole Verdun share their advice and best practices for small and emerging biotechs when working with the FDA.

  2. DynaDrive Single-Use Bioreactors Drilled-Hole Sparge Technology 3/30/2026

    Uniform bubble size and consistent mass transfer across scales through drilled-hole sparge technology improves oxygen delivery and CO2 stripping in demanding cell culture processes.

  3. Understanding AI And Machine Learning's Impact On CGT with Dr. Peter Marks and Dr. Nicole Verdun 1/30/2024

    During this segment, Dr. Peter Marks and Dr. Nicole Verdun share their take on how AI and machine learning will impact FDA regulation in 2024.

  4. Ensure Consistency Across Batches With A Powerful Tool 5/19/2025

    Learn how to streamline bioprocess control with an innovative software's Unit Save and Load feature. Save configurations, reduce setup time, and ensure consistency across batches with this powerful tool.

  5. Best Practices For Effective Donor Management 5/6/2024

    Starting with high quality donor material is critical for allogeneic cell therapy drug manufacturing, and this requires laying the groundwork for a high-touch, end-to-end donor pool management strategy.

  6. Maximizing Performance And Quality In Fed-Batch And Perfusion-Based IgG Productions Customer Interview 4/16/2026

    From lab to production scale: a researcher's firsthand account of what bioreactor scaling and high-density perfusion really demand in practice.

  7. Perfusion: Medium Selection And Testing 6/16/2025

    An examination of what to consider in a perfusion medium, including varying reconstituted concentrations, supporting multiple cell clones, allowing for high cell densities at low medium exchange rates, and using it in various types of perfusion.

  8. Tailoring Purification Solutions To Address Customer Challenges 5/21/2025

    Developing purification products for novel biotherapeutics requires close customer collaboration to ensure the tools do the job. Hear how these partnerships drive targeted innovation.

  9. BioTitan Retention Device Overview 5/29/2025

    Learn about a retention device that provides robust fortification for single-use assemblies. Its 360-degree seal strengthens connections, reduces leak risks, and ensures process integrity for fluid transfer.

  10. Take The Lead With The Gibco CHOvantage™ GS Cell Line Development Kit 3/13/2026

    See how this kit accelerates clone development to 14 weeks with ≥7 g/L protein titers while reducing costs through royalty-free commercial licensing for therapeutic applications.